(Q36029095)

11 August 2017

Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma (English)

1 reference

11 August 2017

1 reference

1 reference

1

Ellis IO

1 reference

11 August 2017

Bell J

2

1 reference

11 August 2017

Todd JM

3

1 reference

11 August 2017

Williams M

4

1 reference

11 August 2017

Dowle C

5

1 reference

11 August 2017

Robins AR

6

1 reference

11 August 2017

Elston CW

7

1 reference

11 August 2017

Blamey RW

8

1 reference

11 August 2017

Baldwin RW

9

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 September 1987

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

56

1 reference

11 August 2017

295-299

1 reference

11 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1987.192

11 August 2017

0 references

cites work

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002198

A prognostic index in primary breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002198

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002198

Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002198

The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002198

Estrogen receptor assay in primary breast cancer and early recurrence of the disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002198

The assessment of histological differentiation in breast cancer.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002198

Immunogold-silver staining: new method of immunostaining with enhanced sensitivity

23 September 2018

1 reference

12 December 2020

The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas

1 reference

12 December 2020

Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies

1 reference

12 December 2020

Epitopes with diagnostic and prognostic significance co-expressed on a human breast carcinoma-associated antigen

1 reference

12 December 2020

MAM-6 antigen, a new serum marker for breast cancer monitoring

1 reference

12 December 2020

Survival in breast cancer related to tumour oestrogen receptor status and immunohistochemical staining for NCRC 11

1 reference

12 December 2020

A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterization

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1987.192

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

1 reference